Capital Market Strategies LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Market Strategies LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 4.9% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 2,127 shares of the healthcare conglomerate’s stock after buying an additional 100 shares during the period. UnitedHealth Group makes up about 1.1% of Capital Market Strategies LLC’s investment portfolio, making the stock its 21st biggest position. Capital Market Strategies LLC’s holdings in UnitedHealth Group were worth $1,092,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Signature Estate & Investment Advisors LLC increased its stake in UnitedHealth Group by 1.2% during the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after purchasing an additional 19 shares in the last quarter. Steph & Co. increased its stake in UnitedHealth Group by 1.6% during the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares in the last quarter. First City Capital Management Inc. boosted its holdings in shares of UnitedHealth Group by 1.5% in the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock valued at $688,000 after acquiring an additional 20 shares during the last quarter. Griffin Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 0.3% in the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $3,414,000 after acquiring an additional 21 shares during the last quarter. Finally, Physicians Financial Services Inc. boosted its holdings in shares of UnitedHealth Group by 5.2% in the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock valued at $216,000 after acquiring an additional 21 shares during the last quarter. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $521.02 on Monday. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The stock has a market capitalization of $487.35 billion, a price-to-earnings ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. The firm has a 50-day simple moving average of $529.29 and a 200-day simple moving average of $511.81. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same period last year, the business earned $4.70 earnings per share. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be paid a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a yield of 1.27%. The ex-dividend date is Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction dated Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at $4,043,896. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at $4,043,896. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Insiders sold a total of 140,324 shares of company stock valued at $75,086,185 over the last 90 days. 0.40% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Sanford C. Bernstein downgraded shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. SVB Leerink increased their price target on shares of UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Argus increased their price target on shares of UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a report on Monday, July 25th. Finally, Loop Capital started coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target on the stock. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $585.65.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.